TSX:CURAPharmaceuticals
Curaleaf Reverse Split Targets Uplist And Broader Access To Capital
Curaleaf Holdings (TSX:CURA) has approved a 1-for-3 reverse stock split.
The move is part of the company's plan to uplist its shares to a major U.S. stock exchange.
The company cites broader investor access and preparation for potential regulatory shifts in U.S. cannabis as key reasons for the action.
For investors tracking Curaleaf Holdings at a current share price of CA$4.39, the reverse split comes after a 1-year return of 259.8% and a year-to-date gain of 22.6%. Over the past month the...